VENENUM Biodesign, a Genesis Drug Discovery and Development (GD3) Company, is focused on discovering and advancing innovative new medicines for significant unmet medical needs in key therapeutic areas, including; cancer, inflammation, infectious diseases, metabolic diseases, and women’s health. Our most advanced programs are targeting Clostridium difficile infection (CDI) and Type 2 Diabetes (T2D). Our business model allows us to focus on the creation of high value, innovative small molecule programs against well-validated targets, as well as new targets identified from our own research and to work with partners for clinical and commercial development to bring our products to patients. Our mission is to improve patients’ lives through the discovery of therapeutic compounds against our novel biological targets. Many of our targets involve novel protein-protein or protein-DNA interactions. Others are more conventional target classes e.g., GPCRs and enzymes. Our goal is to advance our discoveries to medicine through partnership with pharmaceutical companies. We utilize state-of-the-art assay development and ultra-high throughput screening (UHTS) against our proprietary 6 million ECLiPS compound collection in conjunction with protein engineering and structural biology, medicinal chemistry, and in vivo models.
View Top Employees from Venenum BioDesign, LLCWebsite | http://www.venenumbiodesign.com |
Revenue | $6 million |
Funding | $350000 |
Employees | 34 (34 on RocketReach) |
Founded | 2009 |
Address | 8 Black Forest Rd, Hamilton, New Jersey 08691, US |
Phone | (609) 587-1827 |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Drug Discovery, Business Services, Science and Engineering, Medicinal Chemistry, High Throughput Screening, Compound Management, ADMET-PK, In Vivo Pharmacology |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Venenum BioDesign, LLC employee's phone or email?
The Venenum BioDesign, LLC annual revenue was $6 million in 2024.
Phil Stein is the Vice President, Chemistry of Venenum BioDesign, LLC.
34 people are employed at Venenum BioDesign, LLC.
Venenum BioDesign, LLC is based in Hamilton, New Jersey.
The NAICS codes for Venenum BioDesign, LLC are [541714, 54171, 5417, 54, 541].
The SIC codes for Venenum BioDesign, LLC are [87, 873].